GERGEN MARK J (President and CBO) reported 1 transaction at POSEIDA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/4/2024ACC: 0000950170-24-024922
DirectorOfficer· President and CBO
Since Jul 2020
-34.16K
Net shares
Net seller
$141.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
34.16K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−34.16K
Price / share
$4.13
Trade value
$141.07K
% of position
5.0%
3/1/2024
685.45K→651.29K
Total
Net shares
−34.16K
Net value
-$141.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −34.16K | $4.13 | $141.07K | 5.0% | 685.45K | 651.29K |
| Total | −34.16K | -$141.07K | ||||||
Derivative Transactions0
No derivative transactions reported